ChromaDex Inc. (CDXC) Starts Presentation at B. Riley Conference
ChromaDex (NASDAQ: CDXC) is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN nicotinamide riboside, sold directly to consumers as TRU NIAGEN, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN is helping the world AGE BETTER. For more information, visit the company's website at www.chromadex.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to…







